Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5040245 | 6069546 | F | 5040245-3 | 20060316 | 20051118 | 20060630 | EXP | PHEH2005US12835 | NOVARTIS PHARMACEUTICALS CORP. | 34 | YR | F | Y | 20060630 | UNITED STATES |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
5040245 | 1007430374 | C | METHYLDOPA | 1 | ORAL | UNK, TID | |||||
5040245 | 1007430375 | C | PRENATAL VITAMINS | 2 | |||||||
5040245 | 1007430376 | PS | LOTREL | 1 | ORAL | 020364 | |||||
5040245 | 1007430377 | SS | LOTREL | 1 | ORAL | 10/20MG | 020364 |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
5040245 | 1007430376 | HYPERTENSION |
Outcome of event
Event ID | OUTC COD |
---|---|
5040245 | OT |
Reactions reported
Event ID | PT |
---|---|
5040245 | DRUG EXPOSURE DURING PREGNANCY |
5040245 | INDUCED LABOUR |
5040245 | PRE-ECLAMPSIA |
5040245 | PREGNANCY INDUCED HYPERTENSION |
5040245 | PREMATURE LABOUR |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
5040245 | 1007430374 | 20050817 | |||
5040245 | 1007430377 | 20050801 |